Stempeutics partners with Cipla for its stem cell drug – Economic Times
Economic Times |
Stempeutics partners with Cipla for its stem cell drug
Economic Times NEW DELHI: Biotech firm Stempeutics Research today said it has inked an out-licensing deal with drug major Cipla for its stem cell therapy product Stempeucel, indicated for treating critical limb ischemia. "Under this agreement, Cipla will get … |
